印度大麻临床研究 - - 需要为研究人员和道德委员会制定指导方针
Prakash Nayak1, Gouri Pantvaidya1, Priya Ranganathan1
1Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Perspectives in clinical research
|August 9, 2023
概括
印度大麻的临床试验受到不断发展的知识和缺乏监管指南的阻碍. 这篇文章为主要调查人员和道德委员会提供了推,以推动大麻研究.
科学领域:
- 药理学和民族植物学
- 药用植物研究 药用植物研究
- 监管科学 监管科学
背景情况:
- 大麻三是一种广泛种植的植物,含有精神活性的delta-9-tetrahydrocannabinol和非精神活性的cannabidiol.
- 全球大麻政策的范围从禁用到合法化,用于医疗和娱乐用途,一些产品被批准用于诸如多发性硬化症和德拉维特综合征等疾病.
- 印度医用大麻的监管格局仍在发展,影响临床研究.
研究的目的:
- 为了解决研究人员和伦理委员会在印度进行大麻临床试验时所面临的挑战.
- 为启动和进行伦理大麻研究提出指导方针和文件要求.
- 为了促进大麻临床研究的进步,等待全面的监管框架.
主要方法:
- 审查目前的全球政策和大麻的监管状况.
- 分析印度机构道德委员会 (IEC) 和首席调查员 (PI) 面临的挑战.
- 制定强制性文件的建议和大麻临床试验的建议指南.
主要成果:
- 印度大麻临床试验的知识基础和监管框架存在重大差距.
- 由于缺乏明确的当地指导和文献,IEC和PI遇到了困难.
- 由于缺乏标准化程序,导致启动关键研究的延迟.
结论:
- 建立明确的指导方针和强制性文件对于印度的伦理和高效的大麻研究至关重要.
- 对PI和IEC的支持对于克服目前在启动临床研究中的局至关重要.
- 需要一个专门的跨学科的监管框架,以充分支持大麻用于各种医疗用途的实用性.
相关概念视频
01:56Ethics in Research
23.1K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.1K
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K